Viracta Therapeutics, Inc. - VIRX Future Profit

VIRX (Viracta Therapeutics Inc.) - company brandmark

Viracta Therapeutics (VIRX) enjoys a high level of credibility within the oncology community due to its precision approach to therapy. The profit change forecast on the GURU.Markets base chart, where the value represents the latest figure, confirms this status. Viracta Therapeutics is commercializing virus activation methods to destroy tumors, while unique patents protect its market niche from generics.

VIRX: Viracta Therapeutics Future Profit 07/04/2022 - 11/18/2026

Viracta Therapeutics Inc. - analytical breakdowns and key metrics (VIRX)

- price and consensus price forecast:
Fundamental company analysis:Viracta Therapeutics, Inc.
Core merchandise of Viracta Therapeutics, Inc.

For Viracta Therapeutics (VIRX), the forward profitability trend reflects the discounted value of expected operating income. This indicator measures the fundamental attractiveness of the business through projected future cash flows. The metric's dynamics are sensitive to cross-market correlations, signaling a potential asset revaluation. For this leader in EBV-oncology therapy, growth in this indicator confirms the commercial potential of the "Kick and Kill" technology. This allows for an assessment of the investment value of developing drugs for the treatment of rare lymphomas.

Key competitors

Future Profit ONC|HALO: Expected Net Income|Future Profit RVMD (RevMed)|AAPG (Ascentage) - Expected Net Income|Projected Future Earnings CGON (cgoncology.com)|URGN - Future Profit|BCAX: Future Profit|PSNL - Projected Future Earnings|Erasca Corp (ERAS) - Expected Profit|Delcath - Expected Net Income|YMAB (Y-mAbs Therapeutics Inc) - Projected Future Earnings|Expected Net Profit Aura Biosciences, Inc. AURA|Projected Future Earnings CADL|Projected Future Earnings Accuray (ARAY)|Expected Profit SELLAS Life Sciences Group Inc. SLS|ACTU - Future Profit|CTOR: Future Profit|Expected Net Income HURA (TuHURA Biosciences Inc.)|TARA (Protara Therapeutics) - Future Profit|Expected Net Profit Fate Therapeutics Corp (FATE)|Future Profit WHWK|Net Profit Forecast TCRX (TScan Therapeutics, Inc.)|Projected Future Earnings CSBR|XBIT - Expected Net Profit|CEL-SCI Corporation - Future Profit|Expected Net Income OSTX|radiopharmtheranostics.com - Projected Future Earnings|ARTV: Expected Profit|ANL (adlainortye.com) - Future Profit|VERU - Company Profit Forecast|TPST (Tempest Therapeutics, Inc.) - Projected Future Earnings|Projected Future Earnings xiliotx.com|Expected Profit Enochian BioSciences (RENB)|Expected Profit MURA (Mural Oncology PLC)|Expected Profit Kairos Pharma Ltd KAPA|Projected Future Earnings OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - Projected Future Earnings|Company Profit Forecast Curis CRIS|APLM: Projected Future Earnings|Future Profit Tharimmune, Inc.|ADVB (Advanced Biomed) - Projected Future Earnings|Genprex - Forward Earnings|Expected Profit calidibio.com (CLDI)|SBFM (Sunshine Biopharma Inc.) - Expected Net Income|Projected Future Earnings XBIO (Xenetic Biosciences)|Salarius Pharmaceuticals (SLRX) - Expected Net Profit|PPBT: Future Profit|Expected Net Income AONC (American Oncology Network, Inc.)|BeOne Medicines (BGNE) - Expected Profit|Checkpoint Therapeutics, Inc (CKPT) - Projected Future Earnings|Expected Profit Elevation Oncology, Inc.|ICAD: Expected Net Income|Expected Profit ikenaoncology.com (IKNA)|Expected Profit NTBL (Notable Labs, Ltd.)|Projected Future Earnings MOR (MorphoSys Inc)|Projected Future Earnings NAYA Biosciences Inc NAYA|AAPGV - Expected Profit